91244-28-9

Upstream product

• 91967-55-4 2,6-diethylbenzyl alcohol 
• 579-66-8 2,6-diethylaniline 
• 69321-60-4 2,6-dibromotoluene 
• 93701-32-7 2,6-dibromobenzyl bromide 
• 1147858-83-0 acetic acid 2,6-dibromobenzyl ester 
• 1147858-84-1 2,6-diethylbenzyl acetate 
• 78114-07-5 2,6-diethylbenzoic acid 
• 15012-37-0 2,6-Diethyl-benzoesaeure-methylester 
• 65232-57-7 1,3-diethyl-2-bromobenzene 

Downstream Products

• 100256-33-5 2-(2,6-diethylphenyl)acetic acid 
• 94959-59-8 (2,6-Diaethyl-phenyl)-malonsaeure-diaethylester 
• 92300-65-7 2,6-Diethyl-phenyl-essigsaeure-ethylester 

Relevant academic research and scientific papers

BENZODIAZEPINONE COMPOUNDS AND METHODS OF TREATMENT USING SAME

The invention provides 1,4-benzodiazepinone compounds, pharmaceutical compositions, and methods of treating autoimmune disorders, chronic inflammatory disorders, and hyperproliferative disorders. For example, the 1,4-benzodiazepinone compounds and pharmaceutical compositions are contemplated to be useful for treating rheumatoid arthritis, graft-versus-host disease, inflammatory bowel disease, and the like.

BENZODIAZEPINONE COMPOUNDS USEFUL IN THE TREATMENT OF SKIN CONDITIONS

The present invention provides a family of benzodiazepinone compounds and pharmaceutical compositions thereof. The present invention also provides methods of treating certain skin conditions, e.g., atopic dermatitis, rosacea, or psoriasis, by administering a benzodiazepinone and methods of reducing the proliferation of keratinocyte cells by exposing such cells to a benzodiazepinone.